2021 ICD-10-CM Code E75.242
Niemann-Pick disease type C
Valid for Submission
E75.242 is a billable diagnosis code used to specify a medical diagnosis of niemann-pick disease type c. The code E75.242 is valid during the fiscal year 2021 from October 01, 2020 through September 30, 2021 for the submission of HIPAA-covered transactions.
The ICD-10-CM code E75.242 might also be used to specify conditions or terms like lipoidosis, niemann-pick disease, type c, niemann-pick disease, type c, acute form, niemann-pick disease, type c, chronic form, niemann-pick disease, type c, subacute form , sphingomyelin/cholesterol lipidosis, etc.
ICD-10: | E75.242 |
Short Description: | Niemann-Pick disease type C |
Long Description: | Niemann-Pick disease type C |
Code Classification
Index to Diseases and Injuries
The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code E75.242 are found in the index:
Approximate Synonyms
The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:
- Lipoidosis
- Niemann-Pick disease, type C
- Niemann-Pick disease, type C, acute form
- Niemann-Pick disease, type C, chronic form
- Niemann-Pick disease, type C, subacute form
- Sphingomyelin/cholesterol lipidosis
Clinical Information
- NIEMANN PICK DISEASE TYPE C-. an autosomal recessive lipid storage disorder that is characterized by accumulation of cholesterol and sphingomyelins in cells of the viscera and the central nervous system. type c or c1 and type d are allelic disorders caused by mutation of the npc1 gene which encodes a protein that mediates intracellular cholesterol transport from lysosomes. clinical signs include hepatosplenomegaly and chronic neurological symptoms. type d is a variant in people with a nova scotia ancestry.
Convert E75.242 to ICD-9 Code
The General Equivalency Mapping (GEM) crosswalk indicates an approximate mapping between the ICD-10 code E75.242 its ICD-9 equivalent. The approximate mapping means there is not an exact match between the ICD-10 code and the ICD-9 code and the mapped code is not a precise representation of the original code.
- 272.7 - Lipidoses (Approximate Flag)
Information for Patients
Genetic Brain Disorders
Also called: Inborn genetic brain disorders
A genetic brain disorder is caused by a variation or a mutation in a gene. A variation is a different form of a gene. A mutation is a change in a gene. Genetic brain disorders affect the development and function of the brain.
Some genetic brain disorders are due to random gene mutations or mutations caused by environmental exposure, such as cigarette smoke. Other disorders are inherited, which means that a mutated gene or group of genes is passed down through a family. They can also be due to a combination of both genetic changes and other outside factors.
Some examples of genetic brain disorders include
- Leukodystrophies
- Phenylketonuria
- Tay-Sachs disease
- Wilson disease
Many people with genetic brain disorders fail to produce enough of certain proteins that influence brain development and function. These brain disorders can cause serious problems that affect the nervous system. Some have treatments to control symptoms. Some are life-threatening.
- Lesch-Nyhan syndrome (Medical Encyclopedia)
- Maple syrup urine disease (Medical Encyclopedia)
- Menkes syndrome (Medical Encyclopedia)
- Neuronal ceroid lipofuscinoses (NCLS) (Medical Encyclopedia)
- Niemann-Pick disease (Medical Encyclopedia)
[Learn More]
Niemann-Pick disease Niemann-Pick disease is a condition that affects many body systems. It has a wide range of symptoms that vary in severity. Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and the signs and symptoms of the condition.Infants with Niemann-Pick disease type A usually develop an enlarged liver and spleen (hepatosplenomegaly) by age 3 months and fail to gain weight and grow at the expected rate (failure to thrive). The affected children develop normally until around age 1 year when they experience a progressive loss of mental abilities and movement (psychomotor regression). Children with Niemann-Pick disease type A also develop widespread lung damage (interstitial lung disease) that can cause recurrent lung infections and eventually lead to respiratory failure. All affected children have an eye abnormality called a cherry-red spot, which can be identified with an eye examination. Children with Niemann-Pick disease type A generally do not survive past early childhood.Niemann-Pick disease type B usually presents in mid-childhood. The signs and symptoms of this type are similar to type A, but not as severe. People with Niemann-Pick disease type B often have hepatosplenomegaly, recurrent lung infections, and a low number of platelets in the blood (thrombocytopenia). They also have short stature and slowed mineralization of bone (delayed bone age). About one-third of affected individuals have the cherry-red spot eye abnormality or neurological impairment. People with Niemann-Pick disease type B usually survive into adulthood.The signs and symptoms of Niemann-Pick disease types C1 and C2 are very similar; these types differ only in their genetic cause. Niemann-Pick disease types C1 and C2 usually become apparent in childhood, although signs and symptoms can develop at any time. People with these types usually develop difficulty coordinating movements (ataxia), an inability to move the eyes vertically (vertical supranuclear gaze palsy), poor muscle tone (dystonia), severe liver disease, and interstitial lung disease. Individuals with Niemann-Pick disease types C1 and C2 have problems with speech and swallowing that worsen over time, eventually interfering with feeding. Affected individuals often experience progressive decline in intellectual function and about one-third have seizures. People with these types may survive into adulthood.
[Learn More]
Code History
- FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
- FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
- FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
- FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
- FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
- FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)